European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative

Creative Commons License

de Graeff N., Groot N., ÖZEN S., Eleftheriou D., Avcin T., Bader-Meunier B., ...Daha Fazla

RHEUMATOLOGY, cilt.58, sa.4, ss.672-682, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1093/rheumatology/key344
  • Dergi Adı: RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.672-682
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objectives The European Single Hub and Access point for paediatric Rheumatology in Europe initiative aimed to optimize care for children with rheumatic diseases. Kawasaki disease (KD) is the most common cause of acquired heart disease in children and an important cause of long-term cardiac disease into adulthood. Prompt diagnosis and treatment of KD is difficult due to the heterogeneity of the disease but is crucial for improving outcome. To date, there are no European internationally agreed, evidence-based guidelines concerning the diagnosis and treatment of KD in children. Accordingly, treatment regimens differ widely. The aim of this study is to provide consensus-based, European-wide evidence-informed recommendations for diagnosis and treatment of children with KD.